Stock DZ
05.06.2018 kl 14:40

I am not sure if you noticed but these last 2 events (partnering focused) both in Ghent and Boston, Pci Biotech was not represented by PW (rather CFO in Ghent and CBDO in Boston). in times where funding and licensing is highly sought after (PF2 start up) you would expect management to go to these events in full force.

On the other hand, this gives me the feeling that PF2 financing is probably already solved, so why bother !!!
Redigert 05.06.2018 kl 14:41 Arkivert